Cubist Systematic Strategies, LLC Gritstone Bio, Inc. Transaction History

Cubist Systematic Strategies, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$0.62 - $2.35 $12,596 - $47,744	20,317 Added 4814.45%	20,739 $12,000
Q1 2024 May 15, 2024	BUY	$1.96 - $2.9 $815 - $1,206	416 Added 6933.33%	422 $1,000
Q2 2023 Aug 14, 2023	SELL	$1.66 - $3.03 $29,312 - $53,503	-17,658 Reduced 99.97%	6 $0
Q1 2023 May 15, 2023	SELL	$2.13 - $3.74 $11,289 - $19,822	-5,300 Reduced 23.08%	17,664 $49,000
Q4 2022 Feb 14, 2023	SELL	$2.17 - $3.92 $388,588 - $701,966	-179,073 Reduced 88.63%	22,964 $79,000
Q3 2022 Nov 14, 2022	SELL	$2.46 - $4.75 $165,582 - $319,722	-67,310 Reduced 24.99%	202,037 $519,000
Q2 2022 Aug 15, 2022	BUY	$1.77 - $4.34 $170,219 - $417,373	96,169 Added 55.53%	269,347 $652,000
Q1 2022 May 16, 2022	BUY	$4.03 - $12.19 $524,794 - $1.59 Million	130,222 Added 303.15%	173,178 $713,000
Q4 2021 Feb 14, 2022	SELL	$8.76 - $13.71 $193,534 - $302,895	-22,093 Reduced 33.96%	42,956 $552,000
Q3 2021 Nov 15, 2021	BUY	$6.41 - $13.54 $189,255 - $399,768	29,525 Added 83.11%	65,049 $703,000
Q2 2021 Aug 16, 2021	BUY	$8.13 - $10.2 $4,650 - $5,834	572 Added 1.64%	35,524 $324,000
Q1 2021 May 17, 2021	BUY	$4.07 - $27.11 $142,254 - $947,548	34,952 New	34,952 $330,000
Q3 2020 Nov 16, 2020	SELL	$2.63 - $8.09 $30,981 - $95,300	-11,780 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$5.69 - $8.17 $67,028 - $96,242	11,780 New	11,780 $78,000

35.4M

395K

132K

Ticker GRTS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,006,896
Market Cap $2.19M
Description
Gritstone bio, Inc., a clinical-stage biotechnology company, engages in developing immunotherapies against multiple cancer types and infectious diseases. Its lead product candidate is GRANITE, a neoantigen-based immunotherapy for the treatment of solid tumors, including metastatic non-small cell lung cancer, as well as gastroesophageal, bladder ...

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.